How to select a cell line to produce a biosimilar

Author
Published on

If you are developing a biosimilar of a recombinant protein, you need to select a cell line to produce your product. The easiest choice is to use the same cell line as is used to manufacture the reference product. However, if you cannot use the same cell line due to patent restrictions or business reasons – should you abandon your plans to develop a biosimilar produced in a different cell line? 

Upon reading this paper you will learn what regulatory authorities have to say on this and what pitfalls are lying on your path.

Explore Starodub updates

Major Changes Ahead for CTD Modules 2 & 3: ICH Releases Draft M4Q(R2) for Public Consultation

Nonclinical safety assessment with New Approach Methodologies (NAMs): partner with us for regulatory success! 

Our 2025 company outing was unforgettable

Valentyna Starodub
Founder and Chief Executive Officer
Valentyna Starodub

Let's Connect

Talk to an expert